lung cancer
Conditions
Interventions
cancer patients group:None
control group:None
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.It is clinically and/or pathologically diagnosed as any of 16 cancers such as lung cancer, colorectal cancer, liver cancer and other non-target cancers; 2.40 years old = age < 75 years old; 3.Prior to screening, he had not received any systemic or local anti-tumor therapy, including but not limited to surgical resection, chemoradiotherapy, endocrine therapy, targeted therapy, immunotherapy, cell therapy, interventional therapy, etc; 4.Sign informed consent and agree to follow the sampling, evaluation, and interview requirements for this study.
Exclusion criteria
Exclusion criteria: 1.Pregnant and lactating women; 2.People with a history of other cancers; 3.History of severe acute infectious diseases (such as severe and critical COVID-19 infection, sepsis, etc.) or fever exceeding 38.5 °C within 14 days prior to screening; 4.Use of the following drugs in the 14 days prior to screening: intravenous/oral glucocorticoids; 5.Intravenous/oral use of azacitidine, decitabine, procainamine, hydrazine, arsenic trioxide; 6.Have received an organ transplant, bone marrow transplant, stem cell transplant or blood transfusion within 30 days before screening; 7.Other situations deemed unsuitable for participation in this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity;specificity;Tissue traceability accuracy; | — |
Countries
China
Contacts
Public ContactJun Wang
Peking University People's Hospital
Outcome results
None listed